FibroGen
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell FibroGen and other ETFs, options, and stocks.About FGEN
FibroGen, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer.
CEOThane Wettig
CEOThane Wettig
Employees225
Employees225
HeadquartersSan Francisco, California
HeadquartersSan Francisco, California
Founded1993
Founded1993
Employees225
Employees225
FGEN Key Statistics
Market cap32.93M
Market cap32.93M
Price-Earnings ratio0.20
Price-Earnings ratio0.20
Dividend yield—
Dividend yield—
Average volume25.42K
Average volume25.42K
High today$8.55
High today$8.55
Low today$8.00
Low today$8.00
Open price$8.31
Open price$8.31
Volume24.84K
Volume24.84K
52 Week high$21.94
52 Week high$21.94
52 Week low$4.85
52 Week low$4.85
Stock Snapshot
FibroGen(FGEN) stock is priced at $8.25, giving the company a market capitalization of 32.93M. It carries a P/E multiple of 0.20.
On 2025-12-04, FibroGen(FGEN) stock moved within a range of $8.00 to $8.55. With shares now at $8.25, the stock is trading +3.1% above its intraday low and -3.5% below the session's peak.
Trading volume for FibroGen(FGEN) stock has reached 24.84K, versus its average volume of 25.42K.
The stock's 52-week range extends from a low of $4.85 to a high of $21.94.
The stock's 52-week range extends from a low of $4.85 to a high of $21.94.
People also own
Based on the portfolios of people who own FGEN. This list is generated using Robinhood data, and it’s not a recommendation.